Exploration of the optimal GS-441524 trough concentration for treating COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploration of the optimal GS-441524 trough concentration for treating COVID-19

Published:2023-08 Issue:2 Volume:62 Page:106892
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Nakano Yuki,Inokuchi Yoko,Hayama Tadashi,Hirai Toshinori,Nishiyama Mamoru,Sueyasu Yoshiko,Yokoo Kenjo

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference33 articles.

1. Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline;Chalmers;Eur Respir J,2021

2. Remdesivir and GS-441524 retain antiviral activity against delta, omicron, and other emergent SARS-CoV-2 variants;Pitts;Antimicrob Agents Chemother,2022

3. Remdesivir for the treatment of COVID-19—final report;Beigel;N Engl J Med,2020

4. Population pharmacokinetic modeling of GS-441524, the active metabolite of remdesivir, in Japanese COVID-19 patients with renal dysfunction;Sukeishi;CPT Pharmacometrics Syst Pharmacol,2022

5. Population pharmacokinetics of remdesivir and GS-441524 in hospitalized COVID-19 patients;Leegwater;Antimicrob Agents Chemother,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 therapeutics;Clinical Microbiology Reviews;2024-06-13

2. Remdesivir-Induced Bradycardia and Mortality in SARS-CoV-2 Infection, Potential Risk Factors Assessment: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2023-12-05

3. Pharmacokinetics of GS-441524, the active metabolite of remdesivir, in patients receiving continuous renal replacement therapy: A case series;Journal of Infection and Chemotherapy;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3